3Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellilus.Diabetes Care,2000,23 Suppl 1:S4-19.
4Gabir MM,Hanson RL,Dabelea D,et al.The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction d diabetes.Diabetes Care,2000,23(8):1108-1112.
5Chilcott J,Tappenden P,Jones ML,et al.A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus.Clin Ther,2001,23(11):1792-1823.
6Shulman GI.Cellular mechanisnm of insulin resistance.J Clin Invest,2000,106 (2):171-176.
7Dresner A, Laurent D, Marcucci M, et al. Effects of free fatty acids on glucose transport and IRS-I-assiated phosphatidylinositol 3-kinase activity [J]. J Clin Invest, 1999,103(2) :253-259.
8Hotta K, Funahashi T, Bodkin NL, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys [ J]. Diabetes, 2001,50(5 ) : 1126-1133.
9Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity [J]. Nat Med, 2001,7(8) :941-946.
10Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes [J]. Nature, 2001,409(6818) :307-312.
